Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized Trial

NCT07198451 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Non Muscle Invasive Bladder Cancer

Interventions

DRUG: Gemcitabine Submucosal Injection
DRUG: Gemcitabine Intravesical Instillation

Sponsor

Shanghai University of Traditional Chinese Medicine